-
Economic Burden of Prader-Willi Syndrome Among Pediatric Patients in the United States
Mar 10, 2025, 14:00 PM -
Chimeric Antigen Receptor T Cell (CAR T) Therapy As Second-Line (2L) Treatment for Patients With Relapsed/Refractory Large B-Cell Lymphoma (R/R LBCL): Therapy Choice and Treatment Barriers Among US Oncologists
Mar 10, 2025, 14:00 PM -
An Evaluation of PhlexNeuron, an Internal, Proprietary Artificial Intelligence (AI) Tool for Systematic Literature Review (SLR) Screening
Mar 10, 2025, 14:00 PM -
Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models
Mar 10, 2025, 14:00 PM -
The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective
Mar 10, 2025, 14:00 PM -
The Impact of CDA-AMC Sequential Analysis on Decision-Making in Oncology
Mar 10, 2025, 14:00 PM -
Real-World Treatment Patterns and Clinical Characteristics Among Patients With Crohn’s Disease Receiving First- and Second-Line Biologic Treatments in The United States
Mar 10, 2025, 14:00 PM -
Estimating US Cancer Prevalence With Community Oncology EHR-Based Datasets via National Benchmarks From SEER and NPCR
Mar 10, 2025, 14:00 PM -
Epidemiology, Demography and Comorbidities of Patients With Osteoporosis at Very High Risk of Fracture in China
Mar 10, 2025, 14:00 PM -
Increasing Recognition Towards Inclusion of Patient Preferences in Healthcare Intervention Development and Access- Current Landscape and Way Forward
Mar 10, 2025, 14:00 PM -
The Importance of Medicare Advantage Plan Design and Impact on Health Equity
Mar 10, 2025, 14:00 PM -
Real-world Impact of the United States Preventive Services Task Force (USPSTF) Guidelines on HIV-1 Pre-Exposure Prophylaxis (PrEP) Ancillary Service Cost Sharing: Segmented Change Pre- and Post-Milestone USPSTF Timepoints
Mar 10, 2025, 14:00 PM -
Economic Systematic Literature of Nirmatrelvir+Ritonavir for the Treatment of Patients With Mild to Moderate COVID-19
Mar 10, 2025, 14:00 PM -
An Assessment of Financial Burden and its Association with Desmoid Tumor Specific Symptoms and Impacts in Adult Desmoid Tumor Patients: Desmoid Tumor Research Foundation Natural History Study
Mar 10, 2025, 14:00 PM -
Psychometric Evidence Supporting the Use of the EQ-5D in Long COVID: A Systematic Review
Mar 10, 2025, 14:00 PM -
Emerging Trends in AI Applications: Shaping Pharmacoepidemiology and Health Technology Assessments
Mar 10, 2025, 14:00 PM -
Strategic Implications of EU HTAR (JCA and JSC) for Global Biopharma and Biotechs: Navigating Evolving Paradigms in Market Access
Mar 10, 2025, 14:00 PM -
Use of Real-World Evidence in HTA Submissions and Cost-Effectiveness Evaluations in Asia
Mar 10, 2025, 14:00 PM -
The Burden of Migraine in Brazil's Private Healthcare System: Results From the Brazil Migraine Real-World Evidence (BREM) Study
Mar 10, 2025, 14:00 PM -
Hemoglobin Levels and Social Determinants of Health as Risk-factors of End-Organ Damage in Sickle Cell Disease: A Retrospective Analysis
Mar 10, 2025, 14:00 PM
